Health Condition 1: E039- Hypothyroidism, unspecified
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Willingness to participate in the study and provide informed consent. Male and female patients between the ages of 20 60 years. Patients with hypothyroidism with TSH levels ranging from 10 mlU/L- 25 mlU/L Patients who are stable dose of Levothyroxine therapy since last 3-6 months but their TSH level is not in within range with this dose
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary outcome of the study will be the change in TSH levels from baseline to the end of the treatment period. Timepoint: FROM BASELINE TO 60 DAYS | — |
Secondary
| Measure | Time frame |
|---|---|
| To change in the intensity of the symptoms associated with hypothyroidism comparative effect of these two drugs Timepoint: FROM BASELINE TO 60 DAYS | — |
Countries
India
Contacts
National Institute Of Ayurveda Jaipur